"Harbin Clinic Cancer Center is a hub for all of your cancer care needs, uniting our community in the fight against cancer. The beginning of a cancer journey is full of unknowns, and our job is to help you be prepared."

During the past decade, Regional Radiation Oncology Center at Rome conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Radiation Oncology Center at Rome" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "Danish Head and Neck Cancer Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Regional Radiation Oncology Center at Rome" are "Head and Neck Cancer" (6 trials), "Brain and Central Nervous System Tumors" (4 trials), "Lung Cancer" (4 trials), "Radiation Toxicity" (4 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Regional Radiation Oncology Center at Rome" in a lesser frequency.

Most popular intervention types in "Regional Radiation Oncology Center at Rome" are "Radiation" (22 trials), "Drug" (21 trials), "Procedure" (13 trials), "Biological" (7 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (23 trials), "conventional surgery" (8 trials), "cisplatin" (5 trials), "paclitaxel" (5 trials) and "filgrastim" (4 trials). Other intervention names were less common.

The vast majority of trials in "Regional Radiation Oncology Center at Rome" are 24 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Regional Radiation Oncology Center at Rome". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Regional Radiation Oncology Center at Rome, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Radiation Oncology Center at Rome, 6 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".